Takeda Pharmaceutical Co Ltd

General

Total Cases124
Active Cases14
Patents2,016
CourtsD. DelawareD. New JerseyS.D. New York
TypeOperating Company
Elite Ratings
--
--
--
--

Ratings

Experience
Grade
Trend
DCT
L4
A
PTAB
L4
E
CAFC
L4
A

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
11/21/24
Azurity Pharmaceuticals Inc v. Hetero Labs Ltd
1:24-CV-00396
 (
D. DE
)
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # [1] Stipulation of Dismissal)(mdb) (Entered: 11/21/2024)
11/21/24
Azurity Pharmaceuticals Inc v. Hetero Labs Ltd
1:24-CV-00396
 (
D. DE
)
SO ORDERED re [21] Stipulation of Dismissal ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 11/21/2024. (dlw) (Entered: 11/21/2024)
11/20/24
Azurity Pharmaceuticals Inc v. Hetero Labs Ltd
1:24-CV-00396
 (
D. DE
)
STIPULATION of Dismissal without prejudice by Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Zare, Maliheh) (Entered: 11/20/2024)
11/12/24
Azurity Pharmaceuticals Inc v. Hetero Labs Ltd
1:24-CV-00396
 (
D. DE
)
SO ORDERED re [20] STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to the Complaint to December 11, 2024 (Set/Reset Answer Deadlines: Hetero Labs Limited answer due 12/11/2024; Hetero Labs Limited Unit-V answer due 12/11/2024; Hetero USA Inc. answer due 12/11/2024). ORDERED by Judge Maryellen Noreika on 11/12/2024. (dlw) (Entered: 11/12/2024)
11/08/24
Azurity Pharmaceuticals Inc v. Hetero Labs Ltd
1:24-CV-00396
 (
D. DE
)
STIPULATION TO EXTEND TIME to move, answer, or otherwise respond to the Complaint to December 11, 2024 - filed by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc.. (Stamoulis, Stamatios) (Entered: 11/08/2024)
10/08/24
Azurity Pharmaceuticals Inc v. Hetero Labs Ltd
1:24-CV-00396
 (
D. DE
)
SO ORDERED re [19] STIPULATION TO EXTEND TIME to Move, Answer or Otherwise Respond to the Complaint to November 11, 2024 (Set/Reset Answer Deadlines: Hetero Labs Limited answer due 11/11/2024; Hetero Labs Limited Unit-V answer due 11/11/2024; Hetero USA Inc. answer due 11/11/2024). ORDERED by Judge Maryellen Noreika on 10/8/2024. (dlw) (Entered: 10/08/2024)
10/07/24
Azurity Pharmaceuticals Inc v. Hetero Labs Ltd
1:24-CV-00396
 (
D. DE
)
STIPULATION TO EXTEND TIME to Move, Answer or Otherwise Respond to the Complaint to November 11, 2024 - filed by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc.. (Stamoulis, Stamatios) (Entered: 10/07/2024)
09/12/24
Azurity Pharmaceuticals Inc v. Zydus Pharmaceuticals USA Inc
1:23-CV-00833
 (
D. DE
)
NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited's Initial Invalidity Contentions filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 09/12/2024)
09/11/24
Azurity Pharmaceuticals Inc v. Hetero Labs Ltd
1:24-CV-00396
 (
D. DE
)
SO ORDERED re [18] STIPULATION TO EXTEND TIME to Move, Answer or Otherwise Respond to the Complaint to October 11, 2024 (Set/Reset Answer Deadlines: Hetero Labs Limited answer due 10/11/2024; Hetero Labs Limited Unit-V answer due 10/11/2024; Hetero USA Inc. answer due 10/11/2024). ORDERED by Judge Maryellen Noreika on 9/11/2024. (dlw) (Entered: 09/11/2024)
09/10/24
Azurity Pharmaceuticals Inc v. Hetero Labs Ltd
1:24-CV-00396
 (
D. DE
)
STIPULATION TO EXTEND TIME to Move, Answer or Otherwise Respond to the Complaint to October 11, 2024 - filed by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc.. (Stamoulis, Stamatios) (Entered: 09/10/2024)